Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search by country: Algeria
Woman and Man Max 99 years
nct
Update Il y a 4 ans
Diabetes Attitudes Wishes and Needs
The study is conducted in Africa, Asia, Europe, Japan, North America and South America. The multinational surveys will explore the experiences and unmet needs of people with diabetes, as ...
Country
Algeria
,
Canada
,
China
,
Denmark
,
France
,
Germany
,
India
,
Italy
,
Japan
,
Mexico
,
Netherlands
,
Poland
,
Russian Federation
,
Spain
,
Turkey
,
United Kingdom
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 4 ans
APROVE : Irbesartan in Hypertension
Study objective : To compare efficacy and tolerability of posology adaptation of Irbesartan in ambulatory Hypertensive patients
Country
Algeria
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 4 ans
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
This trial is conducted in Africa, Asia and Europe. The aim of the trial is to compare the efficacy and safety of insulin degludec/insulin aspart and BIAsp 30 (biphasic insulin aspart 30) ...
Country
Algeria
,
Bulgaria
,
Croatia
,
Czech Republic
,
Germany
,
Poland
,
Romania
,
Slovakia
,
Turkey
,
Ukraine
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
nct
Update Il y a 4 ans
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
MARILIA is a prospective, non-interventional, multicenter study. The purpose of this study is to describe the acceptability of Amenorrhea in contraception indication of Mirena users during...
Country
Algeria
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 4 ans
H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer
This observational study will assess the safety of Herceptin (trastuzumab) in patients with HER2-positive breast cancer in routine clinical practice. Eligible patients will be followed for...
Country
Algeria
,
Morocco
organs
None
Specialty
None
Closed trial
More information